InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Fischer Frank M, 董事. Insider active across 3 companies, notably NEVRO CORP. In total, 20 reports have been recorded. Activity tracked since 25 May 2021. The latest transaction was disclosed on 20 March 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Fischer Frank M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
1,826 股@ US$13.0052.6% 占其流量Common StockSEC:0001297260-26-000003:0
1,431 股@ US$16.5925.5% 占其流量Common StockSEC:0001297260-25-000006:0
2,389 股@ US$9.9434.1% 占其流量Common StockSEC:0001297260-25-000004:0
4,469 股@ US$4.49100.0% 占其流量Common StockSEC:0001415889-25-018088:0
1,159 股0Common StockSEC:0001610717-24-000200:0
778 股0Common StockSEC:0001610717-24-000004:0
871 股0Common StockSEC:0001610717-23-000303:0
658 股0Common StockSEC:0001610717-23-000196:0
6,754 股0Common StockSEC:0001610717-23-000077:0
6,207 股@ US$1.62100.0% 占其流量Common StockSEC:0001575872-23-000843:0
463 股0Common StockSEC:0001140361-23-016284:0
422 股0Common StockSEC:0001567619-23-000251:0
359 股0Common StockSEC:0001567619-22-018214:0
382 股0Common StockSEC:0001567619-22-013692:0
4,155 股0Common StockSEC:0001567619-22-011891:0
231 股0Common StockSEC:0001567619-22-008044:0
206 股0Common StockSEC:0001567619-22-000340:0
143 股0Common StockSEC:0001567619-21-017863:0
101 股0Common StockSEC:0001567619-21-012950:0
1,167 股0Common StockSEC:0001567619-21-011221:0
20 条申报中的 20 条
About Fischer Frank M
Fischer Frank M is a Director at NEVRO CORP, NeuroPace Inc and Tenon Medical, Inc. The declarant has 20 filings in total, and the 20 sampled filings cover the period from 2021-05-26 to 2026-03-23. In these recent filings, the modal transaction nature is Attribution, with individual amounts shown notably at NeuroPace Inc on 2026-03-23, 2025-12-23, 2025-09-22 and 2025-06-24, as well as at Tenon Medical, Inc. on 2023-05-24 and at NEVRO CORP on 2026-04-02.
